1. Home
  2. AKR vs ADMA Comparison

AKR vs ADMA Comparison

Compare AKR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$21.94

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$7.56

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKR
ADMA
Founded
1993
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
AKR
ADMA
Price
$21.94
$7.56
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$22.25
$25.67
AVG Volume (30 Days)
844.4K
5.8M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
0.22
0.19
Revenue
$410,757,000.00
$42,219,783.00
Revenue This Year
$3.21
$27.46
Revenue Next Year
$12.17
$22.11
P/E Ratio
$98.64
$41.58
Revenue Growth
14.20
43.85
52 Week Low
$18.04
$7.21
52 Week High
$22.50
$22.37

Technical Indicators

Market Signals
Indicator
AKR
ADMA
Relative Strength Index (RSI) 56.49 27.46
Support Level $19.61 $7.34
Resistance Level $22.32 $16.61
Average True Range (ATR) 0.36 0.29
MACD 0.00 0.02
Stochastic Oscillator 67.49 5.60

Price Performance

Historical Comparison
AKR
ADMA

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: REIT Portfolio segment consists of high-quality retail properties located in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds the retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: